Arthritis Information

Johns Hopkins Arthritis Center

  • Home
  • Our Center
    • Our Faculty
    • Our Staff
    • About Our Site
  • Appointments
  • Disease Information
    • Rheumatoid Arthritis
    • Psoriatic Arthritis
    • Ankylosing Spondylitis
    • Osteoarthritis
    • Gout
    • Osteoporosis
    • Fibromyalgia
    • Lyme Disease
  • Arthritis News
    • Rheumatoid Arthritis News
    • Psoriatic Arthritis News
    • Ankylosing Spondylitis News
    • Osteoarthritis News
    • Gout News
    • Osteoporosis News
    • Lupus News
    • Fibromyalgia News
  • Patient Corner
    • Arthritis Drug Information Sheets
    • Managing Your Arthritis
    • Educational Videos for Patients
  • Ask The Expert
    • Ask a Question
  • Physician Corner
    • RAVE: The Rheumatoid Arthritis Vital Education Initiative
    • Rheumatology Conference
    • Rheumatology Rounds
    • Case Rounds
    • Radiology Rounds
    • Pathophysiology of the Rheumatic Diseases
  • Arthritis Research
    • Research Studies
    • Support Arthritis Research
You are here: Home / Patient Corner / How to Give a Subcutaneous Injection / How to Inject Orencia

How to Inject Orencia

Updated: November 28, 2012

Victoria Ruffing, RN

About Victoria Ruffing, RN

Ms. Ruffing has been a member of the Arthritis Center since 2000, currently serving as the Nurse Manager. She is a critical member of our patient care team.

Learn How to Inject Videos

  • How to Inject Simponi
  • How to Inject Orencia
  • How to Inject Methotrexate
  • How to Inject Humira
  • How to Inject Enbrel
  • How to Inject Cimzia

Drug Information Sheets

  • Adalimumab (Humira™)
  • Alendronate (Fosamax®)
  • Anakinra (Kineret®)
  • Azathioprine (Imuran®)
  • Celecoxib (Celebrex®)
  • Certolizumab (Cimzia®)
  • Corticosteroids (i.e. Prednisone)
  • Etanercept (Enbrel®)
  • Febuxostat (Uloric®)
  • Golimumab (Simponi®)
  • Hyaluronate (Synvisc® & Hyalgan®)
  • Hydroxychloroquine (Plaquenil®)
  • Ibandronate Sodium (Boniva®)
  • Leflunomide (Arava®)
  • Methotrexate
  • Narcotic Analgesics
  • Non-Steroidal Anti-inflammatory Drugs
  • Pegloticase (KRYSTEXXA®)
  • Risedronate (Actonel®)
  • Rituximab (Rituxan®)
  • Rofecoxib (Vioxx®)
  • Sulfasalazine (Azulfidine®)
  • Teriparatide (Forteo®)
  • Tocilizumab (Actemra®)
  • Valdecoxib (Bextra®)
  • Zolendronic Acid (Reclast®)

8th Annual: Advances in the Diagnosis and Treatment of the Rheumatic Diseases

U.S. News and World Report Rankings Badge

Get our Newsletter!

Complete the information below to stay up to date with the latest information from the Johns Hopkins Arthritis Center.
* = required field
Interested in:


Johns Hopkins Rheumatology

  • Johns Hopkins Rheumatology
  • Arthritis Center
  • Lupus Center
  • Myositis Center
  • Scleroderma Center
  • Sjogren’s Syndrome Center
  • Vasculitis Center
All information contained within the Johns Hopkins Arthritis Center website is intended for educational purposes only. Physicians and other health care professionals are encouraged to consult other sources and confirm the information contained within this site. Consumers should never disregard medical advice or delay in seeking it because of something they may have read on this website.

Return to top of page

Copyright Johns Hopkins Arthritis Center © 2013